linjc16/ctgov huggingface dataset:
Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?

Study Overview
=================
Brief Summary
-----------------
The implementation of nursing urinanlysis protocols based off of symptoms of urinary infections will significantly decrease the length of a patient's stay in the Emergency Department.

Official Title
-----------------
A Randomized Controlled Trial Showing the Effect of Patient Lenght of Stay in the Emergency Department Through Utilizing a Urinalysis Nursing Protocol.

Conditions
-----------------
Urinary Tract Infections

Intervention / Treatment
-----------------
* Other: Urinanlysis


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patients between 16 and 65 years of age complaining of any of the following: dysuria, hematuria, urinary frequency, urinary urgency Exclusion Criteria: any person less than 16 or greater than 65 years of age, history of kidney disease or transplant, foley catherization within the last 30 days, on immuno-suppresent and/or receiving chemotherapy

Ages Eligible for Study
-----------------
Minimum Age: 16 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: 1<br>Recieves urinalysis by nurse per set protocol based off of inclusion criteria | Other: Urinanlysis<br>* sending a Urine sample to the laboratory for processing<br>* Other names: UA;|
| No Intervention: 2<br>ordering of test will be up to the treating physician | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Length of Stay in the Emergency Department |  | 1 hour | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Physician decision making on ordering urinalysis based off of chief complaints |  | 1 hour | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
urinary tract infections, urine, urinalysis, urine protocols, urinalysis protocols, nursing protocols, Emergency Department
Robotic Assisted Vertebral Body Augmentation - a Radiation Reduction Tool

Study Overview
=================
Brief Summary
-----------------
Modern orthopedic and spine surgeons strive towards minimizing surgical exposure and towards increased precision in the placement of implants. This trend requires an increased use of fluoroscopic guidance, which leads to increased exposure of the patient, surgeon and the operating room staff to radiation. Robotic assisted spine surgery is routinely performed in the authors' institution for a variety of indications such as degenerative conditions, trauma, tumors , infections and deformity correction11. The objective of this study is to compare the radiation exposure time during robotic guided vertebral body augmentation to the published results for similar surgeries.

Conditions
-----------------
Vertebral Body Augmentation

Intervention / Treatment
-----------------
* Procedure: robotic assisted surgery


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Men and Women Ages 18-85 Exclusion Criteria: Unwillingness to participate the study

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 85 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| radiation<br> | Procedure: robotic assisted surgery<br>* Robotic guidance: SpineAssist™ (Mazor Surgical Technologies, Caesarea, Israel), is a bone-mounted miniature robot. It is a semi-active system offering surgical tool guidance while leaving performance of the actual surgical operation, such as the drilling, in the surgeon's hands.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| amount of radiation | amount of radiation is calculated from the DLP (Dose Length Product) |  |
Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section

Study Overview
=================
Brief Summary
-----------------
This was an unblinded randomized controlled trial. Women were randomized to uterine closure with the knotless barbed suture (Stratafix PDS, Ethicon) or Vicryl (Ethicon) at the time of elective cesarean. The primary outcome was closure time of the uterine incision. Also measured were blood loss during incision closure and the use of additional hemostatic sutures. Informed consent was obtained

Official Title
-----------------
Randomized Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section

Conditions
-----------------
Cesarean Section

Intervention / Treatment
-----------------
* Device: Knotless barbed suture
* Device: polyglactin 910


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: elective cesarean elective repeat cesarean Exclusion Criteria: emergent or urgent cesarean PROM chorioamninitis placental abruption placenta previa or accreta known uterine fibroids women with known medical problems such as coagulopathy

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Knotless barbed suture vs conventional suture of uterine incision
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Knotless barbed suture<br> | Device: Knotless barbed suture<br>* uterine incision closure<br>* Other names: Stratafix;|
| Active Comparator: polyglactin 910<br>Vicryl | Device: polyglactin 910<br>* uterine incision closure<br>* Other names: Vicryl;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Uterine incision closure time | uterine incision closure time | 5 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| uterine incision blood loss | uterine incision blood loss | 5 months | 
| hemostatic suture use | hemostatic suture use | 5 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Cesarean, incision, suture,
Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients

Study Overview
=================
Brief Summary
-----------------
In the past, some guidelines advised no oral intake for at least 8 hours before any surgery. However, research has shown risks associated with excessive fasting, such as postoperative insulin resistance, and advantages in shorter fasting protocols, such as reduced postoperative nausea and vomiting. The perioperative fasting guidelines of the European Society of Anaesthesiology focus on preoperative carbohydrates. They hold that it is safe for patients to drink carbohydrate-rich fluids up to 2 hours before elective surgery and that drinking carbohydrate-rich fluids improves subjective well-being, reduces thirst and hunger, and reduces postoperative insulin resistance at an evidence level of 1++. Nevertheless, data on drinking carbohydrate fluids before surgery in elderly patients are limited. In our institution, there are two clinical pathways for total knee arthroplasty according to the surgeons. One difference is whether carbohydrate fluids drink or not before surgery. The purpose of this study, therefore, is to assess gastric volume in fasted elderly patients using ultrasound after they drank carbohydrate fluids 2 hours before surgery and to compare with matched patients using age, body mass index, and comorbidity, who did not drink carbohydrate fluids before surgery.

Official Title
-----------------
Ultrasound Assessment of Gastric Volume in Elderly Patients Undergoing Total Knee Arthroplasty After Drinking Carbohydrate-containing Fluids: A Prospective Observational Non-randomized Comparative Study

Conditions
-----------------
Fasting

Intervention / Treatment
-----------------
* Other: Carbohydrate fluid
* Other: Non-carbohydrate fluid


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients undergoing total knee arthroplasty Age: 65 85 yeas ASA 1 3 Exclusion Criteria: Age < 65 years ASA >= 4 Diabetes mellitus Chronic kidney disease

Ages Eligible for Study
-----------------
Minimum Age: 65 Years
Maximum Age: 85 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Group C<br>Patients drank carbohydrate fluid 2 hours prior to surgery according to the routine fasting protocol by surgeon A. | Other: Carbohydrate fluid<br>* 400 mL carbohydrate fluid<br>|
| Group N<br>Patients did not drink carbohydrate fluid 2 hours prior to surgery according to the routine fasting protocol by surgeon B. | Other: Non-carbohydrate fluid<br>* 0 mL carbohydrate fluid<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Gastric volume | Gastric volume measured before induction of spinal anesthesia using ultrasound | During the gastric volume measuring at preoperative holding area/ an average of 30 minutes |
Data Collection for CAD Evaluation

Study Overview
=================
Brief Summary
-----------------
Mammographical data collection (raw data) for CAD evaluation by VUCOMp software.

Conditions
-----------------
Data Collection

Intervention / Treatment
-----------------
* Other: digital mammography


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: women who underwent a digital mammography imaging Exclusion Criteria: men
Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| data collection<br> | Other: digital mammography<br>* data collection<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Datacollection | No outcome described, only datacollection | 2 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
data mammography
Study of Immune Responses to Influenza Vaccination

Study Overview
=================
Brief Summary
-----------------
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.

Official Title
-----------------
Study of Immune Responses to Influenza Vaccination

Conditions
-----------------
Influenza Vaccination

Intervention / Treatment
-----------------
* Biological: Influenza vaccination


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Community-dwelling adults able to provide consent who need influenza vaccination for standard of care Exclusion Criteria: febrile illness at time of vaccination active malignancy use of immunosuppressing medications blood donation in the past 60 days influenza vaccinated during the preceding 6 months allergic reactions to influenza vaccination

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Basic Science
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Influenza vaccination cohort<br>Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care. | Biological: Influenza vaccination<br>* Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Influenza neutralizing antibody titers |  | 21-42 days |
Diffusion MRI-1 Imaging Database

Study Overview
=================
Brief Summary
-----------------
The purpose of the dMRI-1 data collection study is to establish a database of clinical images and limited medical history information from patients that have previously received a dMRI scan. All data collected will be de-identified. No safety or effectiveness assessments will be completed.

Official Title
-----------------
Diffusion MRI-1 Imaging Database

Conditions
-----------------
Epilepsy, Tumor, Healthy, Other

Intervention / Treatment
-----------------
* Device: dMRI Scan


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient is either ≥ 18 years and has previously received an acceptable dMRI scan(s) with at least 30 unique gradient directions or < 18 years who has previously received an acceptable dMRI scan of any number of unique gradient directions and who is allowed to participate in this type of research project (e.g., IRB/EC approval with waiver of consent) per IRB/EC Acceptable dMRI scan was completed prior to site activation in the study Exclusion Criteria: None
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Device: dMRI Scan|Data will be collected from cases where dMRI scans were obtained as part of the subject's previous treatment.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Image assessment |  | Procedure |
Incidence and Neonatal Outcome of Eclamptic Parturient in Tertiary Hospital.

Study Overview
=================
Brief Summary
-----------------
Eclampsia is a rare but serious disease that can happen during the pregnancy. Both general and regional anesthesia can both be performed in eclamptic patients. Eclamptic patients has greater risk if undergo general anesthesia such as risks associated with general anesthesia in pregnancy and also cerebral hemorrhage risks from hypertension during laryngoscope application and thrombocytopenia that can happen in eclamptic patients. So, most of Anesthesiologists tend to avoid performing general anesthesia in these patients. But spinal anesthesia also has side effects such as hypotension or epidural hematoma. And nowadays there's minimal evidence on suitable anesthesia in eclamptic patients. Our study wants to review on how choice of anesthesia affects these patients both mothers and their neonates

Official Title
-----------------
Incidence and Neonatal Outcome of Eclamptic Parturient : a 13-years Retrospective Study From a Single Tertiary Care Center Anesthetic Aspect.

Conditions
-----------------
Eclampsia

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient who diagnosed with eclampsia. Exclusion Criteria: Incomplete medical record.
Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The incidence of eclampsia in Siriraj Hospital. | Incidence represent as percent. | 13 years |
Diagnostic Value of HS-CRP in Stable Angina.

Study Overview
=================
Brief Summary
-----------------
The aim of this study was to assess the amount of additive value of HS-CRP levels to a positive exercise tolerance test (ETT) in predicting coronary artery disease (CAD) using coronary angiography as the gold standard. The investigators concluded that HS-CRP can be used as a single predictor of coronary vessel involvement in patients with stable angina and positive ETT.

Detailed Description
-----------------
the investigators included 97 patients with positive ETT and stable angina and saw that Hs-CRP is the only predictor of severity of CAD as compared with coronary angiography in stable angina patients.

Official Title
-----------------
Diagnostic Value of HS-CRP in Stable Angina Patients With Positive Exercise Test as Compared With Coronary Angiography.

Conditions
-----------------
Stable Angina, Positive ETT

Intervention / Treatment
-----------------
* Procedure: coronary angiography


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Stable angina Positive ETT Exclusion Criteria: Unability to perform ETT Contraindications for ETT and angiography study

Ages Eligible for Study
-----------------
Minimum Age: 43 Years
Maximum Age: 64 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: 1<br>positive ETT, High HS-CRP | Procedure: coronary angiography<br>* effect of level of HS-CRP<br>|
| Active Comparator: 2<br>positive ETT, Low HS-CRP | Procedure: coronary angiography<br>* effect of level of HS-CRP<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| significant coronary lesion |  |  | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| severity of CAD |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Exercise tolerance test, HS-CRP, Coronary angiography, Patients
The Effect of Cocoa Flavonoids on Blood Pressure

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to compare the effects on blood pressure of a daily intake of a flavonoid-rich cocoa drink with that of the same drink from which the flavonoids have been largely extracted.

Detailed Description
-----------------
Flavonoids are natural substances found in fruits and vegetables, tea and red wine. The investigators know that people who eat a diet rich in these foods are less likely to have heart disease. This, in part, may be due to the blood pressure lowering effect of flavonoids. Cocoa beans are a rich natural source of flavonoids. Unfortunately when cocoa is made into chocolate most of the flavonoids are destroyed. The aim of this study is to find out the effect of cocoa flavonoids on blood pressure after 12 weeks of daily consumption of a specially prepared chocolate drink that is rich in flavonoids.

Official Title
-----------------
The Effect of Cocoa Polyphenols on Various Cardiovascular Measurements Including Blood Pressure

Conditions
-----------------
Hypertension

Intervention / Treatment
-----------------
* Behavioral: Flavonoid rich or flavonoid depleted chocolate drink


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Males or females of any age. Diagnosis of hypertension and on antihypertensive treatment. Stable blood pressure that has reached the British Hypertension Society (BHS) audit standard (<150/90mmHg). Exclusion Criteria: Participation in another clinical trial. Any reason to suspect that the patient will not comply with drinking a chocolate beverage every day for the trial duration.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Intervention/Treatment |
| --- |
|Behavioral: Flavonoid rich or flavonoid depleted chocolate drink|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Difference in mean 24 hour ambulatory blood pressure |  |  | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Difference in cholesterol |  |  | 
| Difference in glucose |  |  | 
| Difference in insulin |  |  | 
| Difference in echocardiogram |  |  | 
| Difference in pulse wave velocity |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
randomised double blind trial, blood pressure, cocoa flavonoids